<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(Suppl 2)</volume><submitter>Taylor M</submitter><journal>Journal for immunotherapy of cancer</journal><pagination>P376-P376</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4649441</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032</pubmed_title><pmcid>PMC4649441</pmcid><pubmed_authors>de Braud F</pubmed_authors><pubmed_authors>Horn L</pubmed_authors><pubmed_authors>Christensen O</pubmed_authors><pubmed_authors>Lopez-Martin J</pubmed_authors><pubmed_authors>Simon J</pubmed_authors><pubmed_authors>Morse M</pubmed_authors><pubmed_authors>Antonia S</pubmed_authors><pubmed_authors>Ascierto P</pubmed_authors><pubmed_authors>Taylor M</pubmed_authors><pubmed_authors>Jager D</pubmed_authors><pubmed_authors>Ott P</pubmed_authors><pubmed_authors>Pietanza M</pubmed_authors><pubmed_authors>Lin C</pubmed_authors><pubmed_authors>Bendell J</pubmed_authors><pubmed_authors>Le D</pubmed_authors><pubmed_authors>Eder J</pubmed_authors><pubmed_authors>Calvo E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032</name><description/><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jan</publication><modification>2025-04-26T19:29:54Z</modification><creation>2025-04-06T16:08:03.263Z</creation></dates><accession>S-EPMC4649441</accession><cross_references/></HashMap>